Clinical Trials Browser

OTHER × Melanoma × denileukin diftitox × Clear all

NCT00945269 2022-11-15

Therapeutic Autologous Lymphocytes, Aldesleukin, and Denileukin Diftitox in Treating Patients With Stage III-IV Melanoma

Phase 1/2 Terminated

Melanoma

NCT00515528 2021-01-26

Vaccination Plus Ontak in Patients With Metastatic Melanoma

Phase 2 Terminated

17 enrolled 7 charts

Melanoma

NCT00299689 2014-09-05

Phase II Trial of Ontak With Metastatic Melanoma

Phase 2 Completed

69 enrolled 3 charts

Melanoma, Neoplasm Metastasis